BridgeMD
New treatment option for Endotracheal Extubation
Official title BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia
ClinicalTrials.gov ID: NCT07204990
What this study is testing
- What it's testing
- During surgery, anaesthetists can use an endotracheal tube (ETT) to facilitate ventilation. At emergence from general anaesthesia, there are two techniques for removal of the ETT: (1) the ETT is removed when the child is waking up in (awake removal); or (2) the ETT is removed while still under anaesthesia(deep removal).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 16
You may be able to join if
- Participant Children 0-16 years,
- 5kg and above,
- presenting for elective, semi-elective or emergency surgery under general anaesthesia
- With airway management planned with an endotracheal tube.
You likely can't join if
- Children with severe cardiopulmonary disease or syndrome
- Children \< 5kg
- Children with a contraindication to deep removal of ETT deep or exchange of ETT to LMA at the end of the case (e.g. high risk of aspiration)
- Children with a known or anticipated difficult airway
- Children remaining intubated post-procedure
- Children undergoing major airway surgery or bronchoscopies
The study team makes the final eligibility decision.
Where it's taking place
- Winston-Salem, North Carolina, United States
- Philadelphia, Pennsylvania, United States
- Nedlands, Western Australia, Australia
- São Paulo, Brazil
- Genova, Italy
- Uppsala, Sweden
- Bern, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Winston-Salem, North Carolina, United States; Philadelphia, Pennsylvania, United States; Nedlands, Western Australia, Australia; São Paulo, Brazil; Genova, Italy; Uppsala, Sweden and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.